Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC

Delayed Quote. Delayed  - 02/11 03:59:48 pm
0.31 USD   -3.13%
02/06 CYCLACEL PHARMA : Announces Receipt of Nasdaq Staff Determination; C..
02/05 Cyclacel Announces Receipt of Nasdaq Staff Determination; Company..
02/02 Cyclacel Pharmaceuticals to Present at the 18th Annual BIO CEO & ..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/05/2016 02/08/2016 02/09/2016 02/10/2016 02/11/2016 Date
0.365(c) 0.3201(c) 0.33(c) 0.32(c) 0.31(c) Last
33 143 93 217 197 490 89 589 98 342 Volume
-3.90% -12.30% +3.09% -3.03% -3.13% Change
More quotes
Financials ($)
Sales 2015 2,03 M
EBIT 2015 -15,8 M
Net income 2015 -13,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 1,62 M
EBIT 2016 -21,5 M
Net income 2016 -19,5 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 5,30x
Capi. / Sales 2016 6,64x
Capitalization 10,8 M
More Financials
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
02/06 CYCLACEL PHARMACEUTICALS : Announces Receipt of Nasdaq Staff Determination; Comp..
02/05 CYCLACEL PHARMACEUTICALS : Notice of Delisting or Failure to Satisfy a Continued..
02/05 Cyclacel Announces Receipt of Nasdaq Staff Determination; Company to Request ..
02/02 Cyclacel Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Con..
01/11 Cyclacel Reviews 2015 Achievements and Announces Key Business Objectives for ..
01/07 CYCLACEL PHARMACEUTICALS : Molecular Basis For Development of Cyclacel's CYC065 ..
2015 CYCLACEL PHARMACEUTICALS : Other Events (form 8-K)
2015 CYCLACEL PHARMACEUTICALS : Molecular Basis for Development of Cyclacels CYC065 C..
More news
Sector news : Bio Therapeutic Drugs
08:52a AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
02/11 LONZA : Education Great Bay, UNH Manchester offer biotech program Department of ..
02/11 FDA panel recommends approval for copy of arthritis drug Remicade
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2015 Shkreli Strikes Again, Brazilian Dam Break Damages Mount - Bezek's Daily Brie..
2015 Midday Gainers / Losers
2015 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
2015 PREMARKET BIOTECH DIGEST : Mylan's Perrigo Bid, MannKind Rallies, Merck's Setbac..
2015 Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q3 2015 Results - Earn..


Comments 
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Technical analysis trends CYCLACEL PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions